Sep 15, 2016 11:30 am UTC| Business
$21 Million in Private Placements, Funded in Two Tranches, Including $5 Million fromSanford Health to Support Type 1 Diabetes Candidate Development $4 Million in a Registered Direct Offering to an Existing Institutional...
Voyager Therapeutics Licenses Novel Gene Therapy Capsids from the California Institute of Technology
Sep 15, 2016 11:05 am UTC| Business
CAMBRIDGE, Mass., Sept. 15, 2016 -- Voyager Therapeutics, Inc. (NASDAQ:VYGR), a clinical-stage gene therapy company developing life-changing treatments for severe diseases of the central nervous system (CNS), today...
2017 TAG Cyber Security Annual Names Imperva a Distinguished Vendor
Sep 15, 2016 11:03 am UTC| Business
REDWOOD SHORES, Calif., Sept. 15, 2016 -- Imperva, Inc. (NYSE:IMPV), committed to protecting business-critical data and applications in the cloud and on-premises, today announced it was named a distinguished vendor by...
NetSol Technologies Announces Fourth Quarter and Full Fiscal Year 2016 Financial Results
Sep 15, 2016 11:01 am UTC| Business
Total Net Revenues Increased 24% Year-over-Year for the Fourth Quarter and 26% for the Full Fiscal Year 2016GAAP Diluted EPS of $0.19 for the Fourth Quarter and $0.32 for the Full Fiscal Year 2016Adjusted EBITDA of $4.1...
pSivida Implements Leadership Change -- Nancy Lurker Named as President and CEO
Sep 15, 2016 11:01 am UTC| Business
WATERTOWN, Mass., Sept. 15, 2016 -- pSivida Corp. (NASDAQ:PSDV) (ASX:PVA), a leader in the development of sustained release drug delivery products primarily for eye diseases, announced that its Board of Directors has...
KemPharm, Inc. Provides Corporate and Clinical Update
Sep 15, 2016 11:00 am UTC| Business
Conference Call and Live Audio Webcast Scheduled for Today at 8:30 a.m. ET KemPharm adjusts product development timelines following full pipeline analysis and positions KP415 and KP201/IR as lead product candidates to...
AxoGen to Participate at 71st Annual American Society for Surgery of the Hand Meeting
Sep 15, 2016 11:00 am UTC| Business
ALACHUA, Fla., Sept. 15, 2016 -- AxoGen, Inc. (NASDAQ:AXGN), a global leader in innovative surgical solutions for peripheral nerve injuries, today announced its participation at the 71st Annual American Society for...